Medical Devices Saudi Arabia

Saudi Arabia Molecular Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Saudi Arabia Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $493.6 Mn Placeholder estimate
Estimate 2025 $550.9 Mn 1.8% of the global market
Projected 2034 $1.48 Bn 168.5% Adds $928.3 Mn over 9 forecast years
CAGR 2025–2034 11.6% Faster than 63% of 193 Medical Devices markets here
Key players 6 +1
  • Saudi Arabia is 1.82% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $550.9 Mn.
  • Fastest growing: Saudi Arabia (this report) at 11.6% a year.
  • Saudi Arabia ranks 1st of 4 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$928.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Molecular Diagnostics Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $493.6 Mn — —
2025 (base) $550.9 Mn +$57.3 Mn —
2026 (forecast) $614.8 Mn +$63.9 Mn +11.6%
2027 (forecast) $686.1 Mn +$71.3 Mn +24.5%
2028 (forecast) $765.7 Mn +$79.6 Mn +39%
2029 (forecast) $854.5 Mn +$88.8 Mn +55.1%
2030 (forecast) $953.6 Mn +$99.1 Mn +73.1%
2031 (forecast) $1.06 Bn +$110.6 Mn +93.2%
2032 (forecast) $1.19 Bn +$123.4 Mn +115.6%
2033 (forecast) $1.33 Bn +$137.8 Mn +140.6%
2034 (forecast) $1.48 Bn +$153.8 Mn +168.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Saudi Arabia Molecular Diagnostics Market Analysis at a glance
Market size, 2025$550.9 Mn placeholder estimate
Forecast, 2034$1.48 Bn placeholder estimate
Growth (CAGR), 2025–203411.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end user (see all)
Key playersRoche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Molecular Diagnostics Market Analysis Executive Summary

Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.

Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).

Bar chart: Saudi Arabia Molecular Diagnostics market size, 2024–2034, placeholder estimates. $493.6 Mn in 2024, $550.9 Mn in 2025 and $1.48 Bn in 2034, 11.6% CAGR.
Saudi Arabia Molecular Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Molecular Diagnostics Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.

Competitive Landscape for Molecular Diagnostics Market in Saudi Arabia

The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Molecular Diagnostics Market in Saudi Arabia

Molecular Diagnostics in Saudi Arabia: rules and payment

Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA).⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Molecular Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Molecular Diagnostics in context

Saudi Arabia compared

  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 10 countries we cover in Middle East.[1]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 10 countries we cover in Middle East.[2]
  • People aged 65 and over: 3.1% of people (2025). World: 10.4% of people (2025). 7th highest of the 10 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Molecular Diagnostics market in Saudi Arabia?
Placeholder estimate: about $550.9 Mn in 2025, rising to about $1.48 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Molecular Diagnostics market in Saudi Arabia growing?
Placeholder estimate: about 11.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Molecular Diagnostics market report cover?
The report splits the market by technology (PCR, Sequencing, Isothermal Amplification, Microarrays and more), application (Infectious Disease, Oncology, Genetic Disease, Blood Screening) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Molecular Diagnostics market?
Key players include Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and Danaher Corporation.
What is driving the Molecular Diagnostics market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Who regulates Molecular Diagnostics in Saudi Arabia?
Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA). Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Saudi Arabia

See all

Related on diagnostics and lab testing and genomics

See the topic